This study aimed to analyze the kinetics of IgM and IgG antibodies against Spike protein subunit 1 (anti-S1) and the receptor-binding domain (anti-RBD) of SARS-CoV-2, as well as the evolution of hematological parameters in hospitalized COVID-19 patients in Peru. This evidence concerns the gene CD40LG and COVID-19.